HCID 117600432, compound → HCID 178422204, compound

Participants

Reaction Steps

The title compound was prepared in a manner similar to Example 303 using 6-(4-(4-cyano-3-fluoro-2-methylphenyl)-5-hydroxy-1H-pyrazol-1-yl)nicotinic acid and (S)—N-methyl-N-(2,2,2-trifluoroethyl)piperidin-3-amine. 1H NMR (400 MHz, DMSO-d6) δ ppm 1.34-1.92 (m, 4 H) 2.26-2.41 (m, 4 H) 2.59-2.80 (m, 2 H) 2.93-3.36 (m, 3 H) 3.55 (br. s., 1 H) 3.75-4.19 (m, 2 H) 4.36-4.54 (m, 1 H) 7.55-7.68 (m, 1 H) 7.71-7.78 (m, 1 H) 8.53 (s, 4 H). ESI-MS m/z [M+H]+ 517.3.

Provenance & Evidence